Table 2.

Table with the statistics of the T2 values from all the patients per region of interest (ROI). The ROIs correspond to normal white matter (nWM), T2-hyperintensity (T2h), T1w-enhancement (T1e) and perilesional area (PER). Column 3: Mean over patients of the T2 ROI statistics. Column 4: 95% CI of the mean over patients of the T2 ROI statistics. Column 5: P-values of the Wilcoxon signed-rank test with the nWM (P-val ROI vs. nWM). Column 6: P-values of the Wilcoxon signed-rank test with the abnormal tissue without T1w-enhancement (P-val ROI vs. T2h). Column 7: P-values of the Wilcoxon signed-rank test with the T1w-enhancement voxels (P-val ROI vs. T1e).

ROI	ROI statistic	Mean (ms)	95% CI (ms)	Pval (ROI vs. nWM)	Pval (ROI vs. T2h)	Pval (ROI vs. T1e)
nWM	Mean	92.33	± 4.43	–	< 0.01*	0.02*
	SD	48.90	± 10.61	–	0.04*	0.02*
	Skewness	10.72	± 1.75	–	< 0.01*	0.02*
	Kurtosis	184.88	± 57.84	–	< 0.01*	0.02*
T2h	Mean	152.25	± 16.06	< 0.01*	–	0.30
	SD	64.63	± 12.34	0.04*	–	0.02*
	Skewness	4.62	± 1.13	< 0.01*	–	0.08
	Kurtosis	42.38	± 13.60	< 0.01*	–	0.08
T1e	Mean	180.05	± 22.52	0.02*	0.30	–
	SD	130.81	± 45.67	0.02*	0.02*	–
	Skewness	3.57	± 0.95	0.02*	0.08	–
	Kurtosis	24.92	± 11.51	0.02*	0.08	–
PER	Mean	103.82	± 9.75	< 0.01*	< 0.01*	0.02*
	SD	63.56	± 24.05	0.01*	0.50	0.16
	Skewness	8.10	± 1.99	< 0.01*	< 0.01*	0.03*
	Kurtosis	111.55	± 54.74	< 0.01*	< 0.01*	0.03*

* indicates p < 0.05.